Both vaccines protect against the two "high-risk-type" strains of HPV, which are responsible, in part, for the development of 70 percent of cervix cancers.
Omabini la mayeza ogonyo akhusela iingxaki ezimbini "zohlobo lomngcipheko ophezulu" zeHPV eziyinxalenye yonobangela wokuvela kwemihlaza yesibeleko ekuma-70 eephesenti.